MetaCap

Seaport Therapeutics (SPTX) News

NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.05-0.27 (-1.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SPTX news summary

We found 4 recent headlines mentioning Seaport Therapeutics (SPTX): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. For price context, SPTX is down 1.47% at $18.05. The most recent story, "Seaport Therapeutics Reports Positive GlyphAllo Data; GlyphAgo Phase 2a Trial Underway", was published by Nasdaq on Nov 2, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Seaport Therapeutics headlines

Stocks mentioned alongside SPTX

Compare SPTX